JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The products will be manufactured at the company's facility in Bengaluru
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Marking a significant milestone in its commitment to holistic wellness
Subscribe To Our Newsletter & Stay Updated